Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $39.2 million.

  • Viemed Healthcare's Shares Outstanding (Weighted Average) rose 82.28% to $39.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year increase of 82.28%. This contributed to the annual value of $38.8 million for FY2024, which is 104.51% up from last year.
  • Per Viemed Healthcare's latest filing, its Shares Outstanding (Weighted Average) stood at $39.2 million for Q3 2025, which was up 82.28% from $39.5 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Shares Outstanding (Weighted Average) registered a high of $39.6 million during Q1 2022, and its lowest value of $38.2 million during Q1 2023.
  • For the 5-year period, Viemed Healthcare's Shares Outstanding (Weighted Average) averaged around $39.0 million, with its median value being $38.9 million (2022).
  • In the last 5 years, Viemed Healthcare's Shares Outstanding (Weighted Average) surged by 288.86% in 2021 and then tumbled by 369.74% in 2023.
  • Quarter analysis of 5 years shows Viemed Healthcare's Shares Outstanding (Weighted Average) stood at $39.5 million in 2021, then fell by 2.12% to $38.7 million in 2022, then decreased by 0.78% to $38.4 million in 2023, then rose by 1.05% to $38.8 million in 2024, then grew by 1.12% to $39.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $39.2 million in Q3 2025, compared to $39.5 million in Q2 2025 and $39.4 million in Q1 2025.